Podcast TCTMD Talking Points

The PARALLAX Trial

February 17, 2021 | Burkert Pieske and C. Michael Gibson discuss sacubitril/valsartan versus individualized RAAS blockade in HFpEF.

Talking Points · Episode 111: The PARALLAX Trial

Listen to previous episodes | Download via iTunes

^{Brought to you by: Edwards Lifesciences}

TCTMD Talking Points

TCTMD Talking Points

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.